Outlook Therapeutics
OTLK
OTLK
27 hedge funds and large institutions have $2.79M invested in Outlook Therapeutics in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.08% more ownership
Funds ownership: 0.07% → 0.15% (+0.08%)
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$769K | |
| 2 | +$212K | |
| 3 | +$106K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$101K |
| 5 |
Two Sigma Investments
New York
|
+$85K |
Top Sellers
| 1 | -$65K | |
| 2 | -$25K | |
| 3 | -$21K | |
| 4 |
MAFM
Mid Atlantic Financial Management
Pittsburgh,
Pennsylvania
|
-$13K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$13K |